Avidity Biosciences
127 hedge funds and large institutions have $872M invested in Avidity Biosciences in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 115 → 127 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.33% less ownership
Funds ownership: 104.79% → 102.46% (-2.3%)
Holders
127
Holding in Top 10
2
Calls
$2.31M
Puts
$24K
Top Buyers
| 1 | +$24.9M | |
| 2 | +$8.49M | |
| 3 | +$7.11M | |
| 4 |
RI
RTW Investments
New York
|
+$6.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.51M |
Top Sellers
| 1 | -$44.3M | |
| 2 | -$14.2M | |
| 3 | -$12.4M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$7.26M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.5M |